Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2013
At a glance
- Drugs Insulin detemir (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Biomarker; Therapeutic Use
- Acronyms SNIFF-LONG 21
- 10 Jun 2017 Biomarkers information updated
- 16 Jul 2013 Secondary endpoint (working memory) results presented at the 2013 Alzheimer's Association International Conference .
- 14 Jul 2013 Primary endpoint 'Verbal-rating-scale' has been met.